Trump administration ending Medicare premium subsidy program
The Trump administration has announced the conclusion of a Medicare premium subsidy program introduced during the Biden administration. Officials stated the decision stems from the belief that the current structure serves insurance companies rather than the people enrolled in the program. This change marks the end of these specific Medicare Part D subsidies as of 2027.
Medicare Part D offers optional prescription drug coverage through private insurers. The program previously underwent restructuring under President Biden, which included a two thousand dollar annual cap on out-of-pocket prescription costs and permitted Medicare to negotiate prices for certain expensive drugs. Those currently receiving these subsidies are now waiting for additional details regarding the impact on their monthly costs.
The Centers for Medicare and Medicaid Services plans to release further cost information in September. According to the agency, the national average monthly bid amount for 2027 is projected at roughly 296 dollars, which will impact federal direct subsidy payments. The base beneficiary premium is set at 41 dollars and 33 cents.
CMS Administrator Dr. Mehmet Oz addressed the decision on social media, describing the move as a way to stabilize the market. He claimed the subsidy was a bailout that is no longer necessary. Oz stated that premiums for most recipients will rise by less than 10 dollars, with some enrollees expected to see lower premiums overall. Officials maintain that beneficiaries will continue to have access to low-cost coverage options and that efforts to lower drug prices will persist.